146 related articles for article (PubMed ID: 7815880)
1. Chlorhexidine or polyhexamethylene biguanide for acanthamoeba keratitis.
Seal DV; Hay J; Kirkness CM
Lancet; 1995 Jan; 345(8942):136. PubMed ID: 7815880
[No Abstract] [Full Text] [Related]
2. Topical polyhexamethylene biguanide (pool cleaner) for treatment of acanthamoeba keratitis.
Yee E; Fiscella R; Winarko TK
Am J Hosp Pharm; 1993 Dec; 50(12):2522-3. PubMed ID: 8122684
[No Abstract] [Full Text] [Related]
3. Polyhexamethylene biguanide treatment for Acanthamoeba keratitis.
Sullivan L
Aust N Z J Ophthalmol; 1998 Feb; 26(1):99. PubMed ID: 9524039
[No Abstract] [Full Text] [Related]
4. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.
Lim N; Goh D; Bunce C; Xing W; Fraenkel G; Poole TR; Ficker L
Am J Ophthalmol; 2008 Jan; 145(1):130-5. PubMed ID: 17996208
[TBL] [Abstract][Full Text] [Related]
5. Is polyhexamethylene biguanide alone effective for Acanthamoeba keratitis?
Tseng SH; Lin SC; Chen FK
Cornea; 1998 May; 17(3):345-6. PubMed ID: 9603394
[No Abstract] [Full Text] [Related]
6. Should we be using polyhexamethylene biguanide to treat Acanthamoeba keratitis?
Kumar B; Crawford GJ
Aust N Z J Ophthalmol; 1997 May; 25(2):94-5. PubMed ID: 9267593
[No Abstract] [Full Text] [Related]
7. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
Polat ZA; Walochnik J; Obwaller A; Vural A; Dursun A; Arici MK
Clin Exp Ophthalmol; 2014 Mar; 42(2):151-8. PubMed ID: 23601234
[TBL] [Abstract][Full Text] [Related]
8. Polyhexamethylene biguanide (0.02%) alone is not adequate for treating chronic Acanthameoba keratitis.
Lam DS; Lyon D; Poon AS; Rao SK; Fan DS
Eye (Lond); 2000 Aug; 14 ( Pt 4)():678-9. PubMed ID: 11040931
[No Abstract] [Full Text] [Related]
9. Comment on: 'A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of Acanthamoeba keratitis'.
Iovieno A; Yeung SN
Eye (Lond); 2022 Feb; 36(2):475-476. PubMed ID: 33514894
[No Abstract] [Full Text] [Related]
10. Response to 'Comment on: 'A randomized masked pilot clinical trial to compare the efficacy of topical 1% Voriconazole ophthalmic solution as monotherapy to combination therapy with topical 0.02% Polyhexamethylene biguanide and 0.02% Chlorhexidine in the treatment of Acanthamoeba keratitis''.
Bagga B; Sharma S; Gour RPS; Joseph J; Mohamed A; Rathi V; Garg P
Eye (Lond); 2022 Feb; 36(2):473. PubMed ID: 33514893
[No Abstract] [Full Text] [Related]
11. Chemotherapy for acanthamoeba keratitis.
Kilvington S
Lancet; 1995 Mar; 345(8952):792. PubMed ID: 7891502
[No Abstract] [Full Text] [Related]
12. Chemotherapy for acanthamoeba keratitis.
Elder MJ; Dart JK
Lancet; 1995 Mar; 345(8952):791-2; author reply 792-3. PubMed ID: 7891501
[No Abstract] [Full Text] [Related]
13. Treatment of Acanthamoeba keratitis combined with fungal infection with polyhexamethylene biguanide.
Tien SH; Sheu MM
Kaohsiung J Med Sci; 1999 Nov; 15(11):665-73. PubMed ID: 10630064
[TBL] [Abstract][Full Text] [Related]
14. The reculture technique: individualizing the treatment of Acanthamoeba keratitis.
Wysenbeek YS; Blank-Porat D; Harizman N; Wygnanski-Jaffe T; Keller N; Avni I
Cornea; 2000 Jul; 19(4):464-7. PubMed ID: 10928758
[TBL] [Abstract][Full Text] [Related]
15. Bilateral radial keratoneuritis resulting from acanthamoeba keratitis.
Lee PY; Lin CC; Chiu LY; Lee PY
Kaohsiung J Med Sci; 2022 Jan; 38(1):79-80. PubMed ID: 34528392
[No Abstract] [Full Text] [Related]
16. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.
Mafra CS; Carrijo-Carvalho LC; Chudzinski-Tavassi AM; Taguchi FM; Foronda AS; Carvalho FR; de Freitas D
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6363-72. PubMed ID: 23900604
[TBL] [Abstract][Full Text] [Related]
17. Acanthamoeba keratitis associated with misuse of daily disposable contact lenses.
Niyadurupola N; Illingworth CD
Cont Lens Anterior Eye; 2006 Dec; 29(5):269-71. PubMed ID: 16945570
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment of Acanthamoeba keratitis with propamidine, neomycin, and polyhexamethylene biguanide.
Varga JH; Wolf TC; Jensen HG; Parmley VC; Rowsey JJ
Am J Ophthalmol; 1993 Apr; 115(4):466-70. PubMed ID: 8470718
[TBL] [Abstract][Full Text] [Related]
19. Polyhexamethylene biguanide in the treatment of Acanthamoeba keratitis.
Mills RA; Wilhelmus KR; Osato MS; Pyron M
Aust N Z J Ophthalmol; 1993 Nov; 21(4):277-8. PubMed ID: 8148148
[No Abstract] [Full Text] [Related]
20. Acanthamoeba keratitis related to cosmetic contact lenses.
Lee JS; Hahn TW; Choi SH; Yu HS; Lee JE
Clin Exp Ophthalmol; 2007 Nov; 35(8):775-7. PubMed ID: 17997788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
